Related Experiment Video
Updated: May 21, 2025

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
48.0K
Targeting C1q prevents microglia-mediated synaptic removal in neuropathic pain
Noosha Yousefpour1,2,3, Shannon N Tansley2,4,5, Samantha Locke1,2
1Dept. of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada.
Nature Communications
|May 17, 2025
Summary
Peripheral nerve injury triggers spinal microglia to engulf synapses, reducing inhibitory connections and causing pain. Targeting the complement pathway, specifically C1q, can block this process and alleviate neuropathic pain.
Area of Science:
- Neuroscience
- Immunology
- Pain Research
Background:
- Microglia activation in the spinal cord is key to neuropathic pain.
- Microglia's role in synaptic pruning during neuropathic pain is not fully understood.
- Immune and neurotrophic signaling by microglia are known factors in pain.
Purpose of the Study:
- To investigate the role of microglial phagocytosis and synaptic pruning in neuropathic pain.
- To determine the specific synaptic changes induced by peripheral nerve injury.
- To identify the molecular pathways involved in microglia-mediated synapse elimination.
Main Methods:
- Inducing peripheral nerve injury in mice.
- Analyzing synapse density in the dorsal horn.
- Utilizing complement-deficient mice (C3 and C4 knockout).
- Administering pharmacological inhibitors of complement protein C1q.
Main Results:
- Peripheral nerve injury leads to microglial engulfment of dorsal horn synapses.
- This process results in a preferential loss of inhibitory synapses, altering the inhibitory/excitatory balance.
- Synapse elimination is dependent on the complement pathway (C3 and C4).
- Inhibition of C1q prevents synapse loss and reduces neuropathic pain.
Conclusions:
- The complement pathway mediates microglia-driven synapse pruning in the spinal cord following nerve injury.
- This pruning, particularly of inhibitory synapses, contributes to persistent neuropathic pain.
- C1q represents a potential therapeutic target for managing neuropathic pain.

